Skip to content
Search

Latest Stories

Sajid Javid visits care home in South London

Health secretary Sajid Javid has said reforms in the social care sector will be a huge priority for him.

“Social care is as important to me as health care. In dealing with the challenges of social care we have understood for a long time now as a government that more needs to be done. We have set out our intention to have significant reform and my predecessor did a lot of work on that with his cabinet colleagues. I am continuing that work and it remains a huge priority for me.”


He made the statement during a visit to a residential care home, Aashna House, at Streatham in South London on Tuesday (July 13).

Javid met the care home  manager, Smita Bhatt, and the rest of her executive team and carers. He spoke to to staff about their working patterns during Covid-19, a government press statement said.

The health secretary also met residents while they were taking part in a traditional Indian dance (Garba), it added.

Javid said he visited the facility to thank care home staff at Aashna House and staff across the country for the incredible work they have been doing.

The health secretary said: “Their job is hard enough in normal times, but of course during the pandemic, it was so much harder. I want to take this opportunity to thank them for what they’re doing and let all care workers know they have the full support of this government.

"During the pandemic we’ve helped them in so many ways with PPE, with testing equipment, with extra funding and that kind of support will continue.”

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less